Stereotaxis (STXS) Cash & Current Investments (2010 - 2026)
Stereotaxis (STXS) reported Cash & Current Investments of $14.6 million for Q1 2026, up 36.74% year-over-year from $10.7 million in Q1 2025, and up 8.9% quarter-over-quarter from $13.4 million in Q4 2025.
Stereotaxis (STXS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Cash & Current Investments data on file, last reported at $14.6 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $14.6 million, up 36.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.6 million (up 36.74% YoY), and the FY2025 annual result was $13.4 million, up 7.92% from the prior year.
- Cash & Current Investments climbed to $14.6 million in Q1 2026 per STXS's latest filing, from $13.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $35.7 million in Q2 2022 and troughed at $7.0 million in Q2 2025.
- A 5-year average of $17.8 million and a median of $14.6 million in 2026 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 79.6% in 2023, then surged 157.67% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $9.1 million in 2022, then surged by 123.28% to $20.3 million in 2023, then tumbled by 38.87% to $12.4 million in 2024, then advanced by 7.92% to $13.4 million in 2025, then increased by 8.9% to $14.6 million in 2026.
- Business Quant data shows STXS's Cash & Current Investments at $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | 14.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.62 Mn |
| Dec 31, 2025 | 13.42 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Jun 30, 2025 | 6.97 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 12.44 Mn |
| Sep 30, 2024 | 11.01 Mn |
| Jun 30, 2024 | 15.16 Mn |
| Mar 31, 2024 | 18.77 Mn |
| Dec 31, 2023 | 20.34 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Jun 30, 2023 | 23.45 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 33.05 Mn |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 35.71 Mn |
| Dec 31, 2021 | 39.19 Mn |
| Sep 30, 2021 | 41.85 Mn |
| Jun 30, 2021 | 45.41 Mn |